Immuneering (IMRX) Other Accumulated Expenses (2022 - 2026)

Immuneering's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $44191.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 21.83% year-over-year to $44191.0; the TTM figure through Mar 2026 stood at $44191.0 (down 21.83% YoY), while the FY2025 annual figure was $291513.0, up 24.76% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $44191.0, down from $291513.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $291513.0 in Q4 2025, with the low at $19796.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $56531.0 (2025), against an average of $96526.3.
• Peak annual rise in Other Accumulated Expenses reached 1212.23% in 2023, while the deepest fall reached 44.23% in 2023.
• Immuneering's Other Accumulated Expenses stood at $19796.0 in 2022, then surged by 1212.23% to $259770.0 in 2023, then retreated by 10.05% to $233665.0 in 2024, then advanced by 24.76% to $291513.0 in 2025, then tumbled by 84.84% to $44191.0 in 2026.
• Business Quant data shows IMRX's Other Accumulated Expenses at $44191.0 in Q1 2026, $291513.0 in Q4 2025, and $80089.0 in Q3 2025.